tiprankstipranks
Trending News
More News >
Whitehawk Therapeutics (WHWK)
NASDAQ:WHWK
US Market

Whitehawk Therapeutics (WHWK) Financial Statements

Compare
499 Followers

Whitehawk Therapeutics Financial Overview

Whitehawk Therapeutics's market cap is currently $127.25M. The company's EPS TTM is $-0.26; its P/E ratio is 19.88; Whitehawk Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 25.98M$ 24.35M$ 15.22M$ 1.12M$ 14.58M
Gross Profit$ -28.07M$ -27.38M$ -18.78M$ -18.55M$ -428.00K
Operating Income$ -67.46M$ -71.93M$ -62.68M$ -111.22M$ -2.55M
EBITDA$ -64.63M$ -71.76M$ -58.80M$ -36.96M$ -2.54M
Net Income$ -63.69M$ -65.77M$ -60.51M$ -110.09M$ -3.48M
Balance Sheet
Cash & Short-Term Investments$ 47.24M$ 108.84M$ 172.56M$ 148.99M$ 4.46M
Total Assets$ 70.32M$ 132.42M$ 184.24M$ 157.91M$ 18.82M
Total Debt$ 833.00K$ 1.27M$ 1.66M$ 605.00K$ 10.26M
Net Debt$ -27.84M$ -61.62M$ -37.36M$ -148.38M$ 5.80M
Total Liabilities$ 17.84M$ 27.23M$ 25.86M$ 21.50M$ 31.26M
Stockholders' Equity$ 52.48M$ 105.19M$ 158.38M$ 136.41M$ -12.43M
Cash Flow
Free Cash Flow$ -61.20M$ -63.63M$ -50.08M$ -22.47M$ -12.70M
Operating Cash Flow$ -59.55M$ -59.66M$ -49.64M$ -22.42M$ -12.70M
Investing Cash Flow$ 25.20M$ 83.21M$ -132.89M$ 25.15M$ 0.00
Financing Cash Flow$ 130.00K$ 326.00K$ 72.62M$ 141.80M$ 1.19M
Currency in USD

Whitehawk Therapeutics Earnings and Revenue History

Whitehawk Therapeutics Debt to Assets

Whitehawk Therapeutics Cash Flow

Whitehawk Therapeutics Forecast EPS vs Actual EPS